Page History
...
These concepts are used in modeling (medicinal product form) concepts in the International Release; they are not allowed to model (clinical drug) concepts in the International Release.
Modeling
...
Pharmaceutical dose form grouper concepts based on intended site shall be modeled using the proximal primitive modeling pattern.
Parent concept | 736542009 |Pharmaceutical dose form (dose form) |
---|---|
Semantic tag | (dose form) |
Definition status |
Defined | |
Attribute: Has dose form intended site | Range: << 736479009 |Dose form intended site (intended site) Cardinality: 0..* |
---|
|
Naming
...
FSN | Use the following pattern for the FSN; align naming |
---|
and case sensitivity with the FSN for the concept that is selected as the attribute value |
. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word |
“and”.
|
|
Example:
CutaneousFor example,
|
|
|
|
| |
Preferred Term | Use the following pattern for the PT; align naming and case sensitivity with the PT for the concept that is selected as the attribute value. For multiple intended sites, the intended sites must be in alphabetical order and separated by the word |
---|
“and”.
|
|
For example,
|
| |
Synonyms | Synonyms are not allowed unless explicitly identified as an exception in the Editorial Guidelines. |
---|---|
Text definitions | Optional |
...
Exemplar
The following illustrates the stated the stated view for grouper concept 740596000 |Cutaneous dose form (dose form)|:
The following illustrates the inferred view for grouper concept 740596000 |Cutaneous dose form (dose form)|:
The following illustrates the stated view for grouper concept 765166009 |Ocular or otic dose form (dose form)|:
The following illustrates the inferred view for grouper concept 765166009 |Ocular or otic dose form (dose form)|: